Calidi Biotherapeutics, Inc. - CLDI

SEC FilingsOur CLDI Tweets

About Gravity Analytica

Recent News

  • 11.10.2025 - Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC
  • 11.04.2025 - Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting
  • 10.30.2025 - Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting
  • 10.22.2025 - Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine

Recent Filings

  • 11.10.2025 - EX-99.1 EX-99.1
  • 11.10.2025 - 8-K Current report
  • 10.31.2025 - 8-K Current report
  • 10.24.2025 - 8-K Current report
  • 10.24.2025 - EX-99.1 EX-99.1
  • 09.19.2025 - 8-K Current report
  • 09.05.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.05.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.05.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.29.2025 - 8-K Current report